ClearMask Archives - Medical Design Sourcing

DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?

DeviceTalks Weekly, powered by MassDevice

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week’s Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they’re making in developing a device to treat diabetes.

In a second interview, bioelectronic device company Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success in treating essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW communit…

DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?

In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is making great strides in developing a device to treat diabetes.

Cala Health CEO Renee Ryan returns to the podcast to give us an update on the Cala Trio’s clinical success in reducing essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW community.

Subscribe today on Apple Podcasts, Spotify, and other players.

DeviceTalks by MassDevice · Can Fractyl Labs and Cala Health go where only drugs have gone before?

The top 5 MassDevice stories of the week — August 21, 2020

COVID-19 continues to dominate medical device industry news on MassDevice.

The pandemic is causing more major lawsuit settling — as well as efforts to offer more medtech to enable better management of the coronavirus.

Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:

5. CureVac raises more than $200M in IPO

CureVac (NSDQ:CVAC) — a Germany-based biotech outfit — is developing a COVID-19 vaccine with backing from the Bill and Melinda Gates Foundation. Read the full story.

4. This telemedicine system could get medtech sales reps back to ORs

Avail Medsystem’s telemedicine system could prove a more efficient way for sales reps to sit in on surgeries, especially as the COVID-19 pandemic continues to hinder access to hospitals. Read the full story.

3. FDA clears ClearMask transparent surgical mas…

FDA clears ClearMask transparent surgical mask

ClearMask announced today that it received FDA 510(k) clearance for its ClearMask fully transparent surgical mask for use in a number of settings.

Baltimore-based ClearMask touts its surgical mask as the first FDA-cleared fully transparent surgical mask for use in hospitals, clinics, schools, retail, hospitality and other settings.

The company said in a news release that the mask meets requirements for fluid resistance and flammability, offering protection for medical use in settings such as an operating room. Additionally, the transparent mask with an anti-fog plastic barrier helps to improve visual communication.

Clearance for the ClearMask could also come at a timely moment as healthcare providers and other frontline workers require protection amid the COVID-19 pandemic. The company has partnered with several distributors to get the masks to as many people who need it as possible, with partners including Cardinal Health Canada, McKesson, Oaktree Produ…